Roche May Test Liberal NJ Expert Standard In Accutane Battle
A New Jersey appellate decision reviving more than 2,000 cases alleging Hoffmann-La Roche Ltd.'s acne medication Accutane caused patients to develop Crohn's disease further affirms the state's looser standard for admitting...To view the full article, register now.
Already a subscriber? Click here to view full article